|
|
 |
| Featured Speakers |
 |
|
|
Dan Bach-Kristensen,
Senior Pharmaceutical Scientist, Nycomed, Denmark
|
 |
|
|
Hans Baumeister,
COO Glycotope GmbH
|
 |
|
|
Jacques Bellalou,
Head of Platform for recombinant protein production in microorganisms, Structural Biology and Chemistry Department, Institut Pasteur, France
|
 |
|
|
Claudio Belluco,
Senior Scientist, CRO - IRCCS, National Cancer Institute, Aviano
|
 |
|
|
Lorenzo Benatuil,
Senior Scientist, Biologics Abbott Bioresearch Center, USA
|
 |
|
|
Berthold Boedeker,
Head of Cell Culture and Pilot Plants, Global Drug Discovery & Biotech Development Bayer Schering Pharma AG
|
 |
|
|
Anne Bondgaard Tolstrup,
Director, Antibody Expression, Symphogen A/S
|
 |
|
|
Christophe Bonny,
CEO, Xigen, Switzerland
|
 |
|
|
Roland Brock,
Chair, Biochemistry of Integrated Systems; Head, Department of Biochemistry, Nijmegen Centre for Molecular Life Sciences, Radboud University
|
 |
|
|
Konrad Buessow,
Team Leader, Division of Structural Biology, Helmholtz Centre for Infection Research
|
 |
|
|
Robin Butler,
Senior R&D Manager, Protein Science MedImmune
|
 |
|
|
Stefan Dübel,
Professor of Biotechnology, Technische Universitaet Braunschweig, Germany
|
 |
|
|
Rainer Fischer,
Senior Executive Director, Fraunhofer-Institute for Molecular Biology and Applied Ecology IME-MB, Germany
|
 |
|
|
Darren Hart,
Team Leader, EMBL, Grenoble
|
 |
|
|
Judith Hartleib,
Group Leader, AstraZeneca
|
 |
|
|
Bernhard Helk,
Section Head Technology Development Novartis Pharma AG, Basel
|
 |
|
|
Stephen Irving,
Senior Principal Scientist, Pfizer Global Research & Development
|
 |
|
|
Thomas Jostock,
Technology/Platform Leader, Novartis Leading Scientist
|
 |
|
|
Ulrike Korf,
Head of Molecular Genome Analysis Department, DKFZ (German Cancer Research Centre
|
 |
|
|
Debbie Law,
CSO, Ablynx
|
 |
|
|
Melvyn Little,
CSO, Affimed Therapeutics AG, Germany
|
 |
|
|
Ton Logtenberg,
CEO Merus
|
 |
|
|
Paolo Martini,
Director, Protein Expressions and Purification Research, Shire Human Genetic Therapies
|
 |
|
|
Judit Nagy,
Director of Proteomics Facility, Imperial College London
|
 |
|
|
Jo Nettleship,
Senior Scientist OPPF-UK, Research Complex at Harwell, Oxford
|
 |
|
|
Malak K. Pirtskhalava,
Head of the Department of Structural Bioinformatics, Institute of Molecular Biology and Biophysics, Tbilisi State University
|
 |
|
|
Andreas Plückthun,
Professor of Biochemistry, University of Zurich
|
 |
|
|
Rick Rutter,
Vice President of Pharmaceutical Sciences Global Biologics, Pfizer
|
 |
|
|
Irina Rybina,
Senior Scientist Group Leader Gene to Protein, High-throughput Biology, Boehringer Ingelheim Pharmaceuticals, Inc. USA
|
 |
|
|
Herwig Schüler,
Team Leader, Structural Genomics Consortium, Karolinkska Institutet, Stockholm
|
 |
|
|
Manfred Schuster,
COO, APEIRON Biologics AG, Vienna, Austria
|
 |
|
|
Arne Skerra,
Professor of Biological Chemistry, Technische Universitaet Muenchen, Freising-Weihenstephan, Germany & Founder and CEO, XL-protein GmbH
|
 |
|
|
Young-Hwa Song,
Head of moleulcar Biol & Biochem Lab, EMBL-Hamburg, Germany
|
 |
|
|
Willem 'Pim' Stemmer,
CEO, Amunix Inc.
|
 |
|
|
Michael Sundstrom,
Managing Director NNF Center for Protein Research, Faculty of Health Sciences, University of Copenhagen
|
 |
|
|
Yvonne Thielmann,
Research Scientist, Department of Molecular Membrane Biology, Max Planck Institute for Biophysics
|
 |
|
|
Barbara Valsasina,
Senior Scientist, Biology Department, Nerviano Medical Sciences
|
 |
|
|
Jan van de Winkel,
President Research & Development and Chief Scientific Officer, GenMab A/S
|
 |
|
|
Dmitry Veprintsev,
Senior Scientist, Paul Scherrer Institute, Switzerland
|
 |
|
|
Peter Vorstheim,
Senior Vice President, BU HESylation® Technology; Kabi Innovation Centre, Fresenius Kabi Deutschland GmbH
|
 |
|
|
Paul Watt,
CSO & CEO Phylogica
|
 |
|
|
Florian Wurm,
Professor of Biotechnology, Laboratory of Cellular Biotechnology, EPFL; Founder and CSO, ExcellGene SA, Switzerland
|
 |
|
|
Zhenping Zhu,
Vice President and Global Head, Protein Sciences and Design, Novartis
|
 |
|
|
Eugene Zhukovsky,
Senior Research Fellow, Boehringer Ingelheim
|
 |
|
|
 |
|
|